Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Operating Expenses (2016 - 2025)

Neuroone Medical Technologies' Operating Expenses history spans 14 years, with the latest figure at $3.3 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 1.85% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $12.4 million, down 0.79%, while the annual FY2025 figure was $12.4 million, 4.62% down from the prior year.
  • Operating Expenses reached $3.3 million in Q4 2025 per NMTC's latest filing, up from $2.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $3.8 million in Q2 2023 to a low of $2.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $3.1 million, with a median of $3.1 million recorded in 2024.
  • Peak YoY movement for Operating Expenses: skyrocketed 36.26% in 2023, then fell 18.06% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $2.8 million in 2021, then increased by 15.15% to $3.2 million in 2022, then rose by 13.31% to $3.7 million in 2023, then dropped by 12.06% to $3.2 million in 2024, then rose by 1.85% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Operating Expenses are $3.3 million (Q4 2025), $2.9 million (Q3 2025), and $2.8 million (Q2 2025).